drugset

drugset / Trial / NCT00116103

A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

NCT00116103 ↗

Phase 2 Completed Astellas Pharma Inc Astellas Pharma US, Inc. · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.

Timeline

Start: 2005-06
Primary completion: —
Completion: 2006-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	—	Inhaled

Indications